Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 215.83 billion as of June 6, 2025. Its market cap has increased by 112.32% in one year.

Market Cap

215.83B

Enterprise Value

330.95B

Revenue

68.62B

Ranking

n/a

PE Ratio

n/a

Stock Price

694.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 215.83B, an increase of 6,685.84%. That is a compound annual growth rate of 15.40%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	215.83B	65.01%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.53T
Celltrion	34.68T
ALTEOGEN	20.36T
Yuhan	7,718.75B
SK Biopharmaceuticals	7,024.70B
HLB Co., Ltd.	6,741.95B
PharmaResearch	4,976.64B
LigaChem Biosciences	3,893.48B

Market Cap Rankings